[Korea ohahreum financial newspaper reporter] SK said that it has 24 days to hold "the 26th Annual General Shareholders' Meeting" in Seoul SK Chilled AM Building Auditorium.
Day general meeting of shareholders in consolidated sales 83.6 trillion won, dwaeteumyeo operating profit of 5 trillion reported in last year's business results, including 300 billion won achieved including the financial statements approval, the Articles of Incorporation some changes, Directors, Audit Committee, senior, stock option grants, directors' remuneration all agenda, including limits approved according to the original bill was passed. Shareholder attendance rate stood at 86%.
Prior to the bill intended to pursue SUPEX jodaesik council chairman, he said, "to increase the competitiveness of existing businesses will emerge as business-type holding company of Global Top Tier level to foster continued ∙ excavations in various growth projects."
As passed some changes to articles of incorporation proposal, companies must consider the welfare of present and future at the same time happy between stakeholders to be committed and sustainable in the long term, achieve harmony and balance, '' the company, as well as to contribute to the economic development and social through value creation and growth along with society, such as information related to the increase of the social enterprise value is added.
The day the General Shareholders' Meeting dwaeteumyeo jangdonghyeon SK㈜ elected as president of corporate directors, Chang Yong-suk was appointed as an outside director and professor of Public Administration at Yonsei. Chang Yong-suk new outside director receives a sociology Ph.D. Stanford University in the United States served as the Prime Minister's Office Government Affairs professional evaluation committee members, including international cooperation with Korea Association for Public Administration.
In addition to this relief it was passed to grant stock options (stock options) to key executives in order to maximize corporate value through responsible management.
SK is showing an integrated holding company launched after the bio ∙ pharmaceutical, semiconductor materials, ICT convergence, etc., and to foster future new business SK material jeuwa SK biotech and other major subsidiary tangible results, such as beating the 20% to 30% earnings one year after the acquisition is.
Recent semiconductor wafers (wafer) and Global Export and accelerate business expansion in the semiconductor materials company LG Siltron argument is ongoing large-scale expansion of biotech drug maker SK.
Financial Daily Economic News FNTIMES - unauthorized reproduction for commercial purposes in accordance with the Copyright Act, No copying, distribution,
Copyright ⓒ Korea's financial newspaper & FNTIMES.com
